Gene therapy firm Generation Bio lands $110 mln Series C

Cambridge, Massachusetts-based Generation Bio, a gene therapy company, has secured $110 million in Series C financing.

Cambridge, Massachusetts-based Generation Bio, a gene therapy company, has secured $110 million in Series C financing. T. Rowe Price led the round.

Source: Press Release